Business Description
ORIENTBIO Inc
ISIN : KR7002630002
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 64.38 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.11 | |||||
Interest Coverage | 8.2 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.08 | |||||
Beneish M-Score | 1.85 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.3 | |||||
3-Year EBITDA Growth Rate | -3.2 | |||||
3-Year Book Growth Rate | 5.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.99 | |||||
9-Day RSI | 32.67 | |||||
14-Day RSI | 35.73 | |||||
6-1 Month Momentum % | -14.61 | |||||
12-1 Month Momentum % | -22.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.65 | |||||
Quick Ratio | 15.05 | |||||
Cash Ratio | 9.82 | |||||
Days Inventory | 114.15 | |||||
Days Sales Outstanding | 71.03 | |||||
Days Payable | 11.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | 6.42 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.17 | |||||
Operating Margin % | 1.35 | |||||
Net Margin % | 8.67 | |||||
FCF Margin % | 10.88 | |||||
ROE % | 3.3 | |||||
ROA % | 2.91 | |||||
ROIC % | 0.89 | |||||
ROC (Joel Greenblatt) % | 10.11 | |||||
ROCE % | 2.82 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.57 | |||||
PE Ratio without NRI | 31.35 | |||||
Price-to-Owner-Earnings | 35.91 | |||||
PS Ratio | 2.21 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 20.38 | |||||
Price-to-Operating-Cash-Flow | 18.31 | |||||
EV-to-EBIT | 12.44 | |||||
EV-to-EBITDA | 5.45 | |||||
EV-to-Revenue | 0.99 | |||||
EV-to-FCF | 9.41 | |||||
Price-to-Graham-Number | 1.08 | |||||
Price-to-Net-Current-Asset-Value | 1.27 | |||||
Price-to-Net-Cash | 2.5 | |||||
Earnings Yield (Greenblatt) % | 8.04 | |||||
FCF Yield % | 4.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ORIENTBIO Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 27,576.679 | ||
EPS (TTM) (â‚©) | 21 | ||
Beta | 0.95 | ||
Volatility % | 27.27 | ||
14-Day RSI | 35.73 | ||
14-Day ATR (â‚©) | 13.00542 | ||
20-Day SMA (â‚©) | 528 | ||
12-1 Month Momentum % | -22.76 | ||
52-Week Range (â‚©) | 496 - 897 | ||
Shares Outstanding (Mil) | 118.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ORIENTBIO Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ORIENTBIO Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
ORIENTBIO Inc Frequently Asked Questions
What is ORIENTBIO Inc(XKRX:002630)'s stock price today?
When is next earnings date of ORIENTBIO Inc(XKRX:002630)?
Does ORIENTBIO Inc(XKRX:002630) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |